Pediatric Pharmacist Review

CBD Use in the Pediatric Population | Pediatric Pharmacist Review

https://meridian.allenpress.com/jppt/article-abstract/28/4/323/494868/Parental-Perceptions-and-Usage-of-Unlicensed?redirectedFrom=fulltextHost-Jena Quinn, PharmD, BCPPSGuest Name- Justin Cole, PharmD, BCPSJustin Cole, PharmD, BCPS, has nearly 2 decades of experience in pediatric pharmacy practice and healthcare innovation. Dr. Cole earned his PharmD from Ohio Northern University.  He began his career at Nationwide Children’s Hospital in Columbus, Ohio, where he developed expertise in general pediatrics, pediatric neurology, and medical education. While at Nationwide Children's he also served on the administrative team, providing leadership of clinical pharmacy services, oversight of investigational drug services, and strategic vision for novel clinical pharmacy solutions to meet the unique needs of children.Dr. Cole now serves as Chair and Associate Professor of Pharmacy Practice at the Cedarville University School of Pharmacy. He is also the founding director of the Cedarville University Center for Pharmacy Innovation. He has been recognized by Cedarville University as Preceptor of Distinction in 2016, Distinguished Pharmacy Faculty Member in 2022, and Faculty Innovator of the Year in 2023. He was also awarded the inaugural award for Excellence in Teaching in Pediatric Pharmacy from the American Association of Colleges of Pharmacy in 2021. Dr. Cole is an active member of the Pediatric Pharmacy Association and the American Society of Health-System Pharmacists. He has authored or co-authored numerous papers and publications, including Ethics in Pharmacy Practice: A Practical Guide. His research and teaching interests include pediatric pharmacy practice, evidence-based communication strategies in pediatrics, practice advancement and innovation, and healthcare ethics. He continues to practice as a pediatric clinical pharmacist at Rocking Horse Community Health Center in Springfield, Ohio.Dr. Cole and his wife Michelle have three wonderful kids. He and his family enjoy hiking, backpacking, backyard gardening, serving in his church, and enjoying sports together.

Impact of Guided Weight-Based Medication Dosing in Pediatric Patients with Obesity | The Pediatric Pharmacist Review

https://www.japha.org/article/S1544-3191(23)00028-6/fulltext
"Hannah Palsgraf went to pharmacy school at Albany College of Pharmacy in upstate NY. She completed her PGY1 at John R. Oishei Children's Hospital in Buffalo, NY and went on to complete her PGY2 in pediatrics through Philadelphia College of Pharmacy with the practice site at Children's Regional Hospital at Cooper in Camden, NJ. She currently practices as a Neonatal ICU Clinical Pharmacy Specialist at Cohen Children's Medical Center in New Hyde Park, NY on Long Island."

Pediatric Obesity | Pediatric Pharmacist Review

Claudia Fox, MD, MPH, is a pediatrician and weight management specialist who specializes in pediatric preventive cardiology and family weight management. She sees patients at University of Minnesota Health Masonic Children's Hospital Pediatric Specialty Care Discovery Clinic, University of Minnesota Health Maple Grove Clinics and the Specialty Clinic for Children in Burnsville. Dr. Fox is also an associate professor as well as fellowship program director and faculty member in the Division of Pediatric Gastroenterology Hepatology and Nutrition in the Department of Pediatrics at the University of Minnesota Medical School.https://publications.aap.org/pediatrics/article/151/2/e2022060640/190443/Clinical-Practice-Guideline-for-the-Evaluation-and?autologincheck=redirected

2020 Focused Updates to the NIH Asthma Management Guidelines | Pediatric Pharmacist Review

This 2020 report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group presents focused updates to the previous 2007 asthma management guidelines on six priority topics.
Dr. Stephen J. Teach Biography Stephen J. Teach, M.D., M.P.H., is the associate dean for Pediatric Faculty Affairs and chair of the department of Pediatrics at George Washington University School of Medicine and Health Sciences; and director and principal investigator of IMPACT DC (Improving Pediatric Asthma Care in the District of Columbia), a care, research, and advocacy program focused on under-resourced and largely minority children with asthma. Dr. Teach also serves as the Washington, D.C., site principal investigator for the NIH/NIAID-funded Inner City Asthma Consortium.
Dr. Teach’s primary academic focus is on inequities in care and outcomes for urban youth with asthma and their families, including their limited access to healthcare services that often results in families seeking episodic asthma care in emergency department settings.
file:///Users/jenaquinn/Downloads/Asthma%20Clinicians%20Guide%20508_02-03-21.pdf
https://www.nhlbi.nih.gov/resources/2020-focused-updates-asthma-management-guidelines

Key Potentially Inappropriate Drugs in Pediatrics (KIDs) List | Pediatric Pharmacist Review

Pediatric Pharmacy Association commissioned a team to create the Key Potentially Inappropriate Drugs in Pediatrics (KIDs) List, an open-access, evidence-based reference aimed at improving medication safety in children.
 
The KIDs List has several potential uses in clinical practice, including incorporating it into electronic health record safety alerts and using it as a clinical reference or teaching tool.
 
 
This episode is sponsored by FRAMEWORK LTC. For more information visit frameworkltc.com

Dr. Allison Chung and Dr. Elizabeth Farrington | The Pediatric Pharmacist Review

Dr. Farrington is a clinical pharmacist at New Hanover Regional Medical Center (NHRMC) in Wilmington, North Carolina. Farrington received a B.S. degree in pharmacy from the University of North Carolina and a Pharm.D. degree from the University of Kentucky (UK), followed by a residency at UK and a pediatric fellowship. Her clinical practice is focused on pediatric critical care and general pediatrics. Recently elected as American College of Clinical Pharmacy (ACCP), President Elect. Dr. Allison Chung and Dr. Elizabeth Farrington discuss how they both got interested in pediatrics and the different paths they took to become pediatric specialty pharmacists.  Potential paths include: Being hired as a staff pharmacy in a Children’s hospital and gaining experience there Doing a PGY1 w/ pediatric emphasis in a pediatric hospital Completing a general PGY1 and then doing a PGY2 in Pediatrics Doing a general PGY1 and then doing a Fellowship in Pediatrics Obtain Board Certification in Pediatric Pharmacy Info can be obtained here: https://www.bpsweb.org/bps-specialties/pediatric-pharmacy/#1517746745397-c50604ba-9a311517780015777151785407768915178583338251517863453680 Also discussed why pediatric pharmacists are important and how pediatric patients are a unique entity that requires specialized knowledge. Discussed some of the things that pediatric pharmacists do and what makes pediatrics so unique. 

Children & COVID 19 Vaccines | The Pediatric Pharmacist Review

We launch the first podcast episode of the Pediatric Pharmacist Review, with our host Dr. Allison Chung, PharmD & Pediatric Critical Care Pharmacist, BCPPS Certified at University of South Alabama Health.  Guest: Dr. Benjamin Estrada Topic: COVID 19 vaccines in pediatrics:  How the different COVID vaccines work. Current information and research on the vaccine’s safety and efficacy in pediatric patients. Has it been tested to the same extent that other vaccines are tested on children? Will the COVID vaccine recommendations include patients younger than 14? When do we think this will happen? What do you say to people who understand that younger patients are less likely to get COVID and less severe symptoms so therefore do not want their children to receive the vaccine? Long term affects of the COVID vaccine on children. Any potential for autism or infertility? Risk vs benefit of COVID vaccine vs getting COVID in children. Many people feel the risk of getting the vaccine is worse because the risk for COVID in children is less and severity of COVID symptoms are less than adults. Suggestions for how pharmacists can encourage vaccination in the pediatric population. At the F.D.A.’s urging, Pfizer-BioNTech and Moderna are expanding their trials for children 5 to 11. NYT: https://www.nytimes.com/2021/07/26/us/politics/fda-covid-vaccine-trials-children.html At the urging of federal regulators, two coronavirus vaccine makers are expanding the size of their clinical trials for children ages 5 to 11 — a precautionary measure designed to detect rare side effects including heart inflammation problems that turned up in vaccinated people younger than 30. President Biden promised at a meeting in Ohio last week that emergency clearance for pediatric vaccines would come “soon,” but the White House has not been specific on the timeline. It was unclear whether expanding the studies will affect when vaccines could be authorized for children. The Food and Drug Administration has indicated to Pfizer-BioNTech and Moderna that the size and scope of their pediatric studies, as initially envisioned, were inadequate to detect rare side effects. Those include myocarditis, an inflammation of the heart muscle, and pericarditis, inflammation of the lining around the heart, multiple people familiar with the trials said. Questions about vaccinating children — including those under 12 — are of huge interest to parents and teachers. Regulators will be required to balance potential side effects of coronavirus vaccination against the risks of Covid-19. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices